{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:52:50Z","timestamp":1791942770769,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001734","name":"K\u00f8benhavns Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Rigshospitalet Forskningspulje"},{"name":"Novo Nordisk Fundation (DK)"},{"DOI":"10.13039\/501100004954","name":"Augustinus Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004954","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003035","name":"Aase og Ejnar Danielsens Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2456-z","type":"journal-article","created":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T14:06:48Z","timestamp":1494943608000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Tryptophan catabolism and immune activation in primary and chronic HIV infection"],"prefix":"10.1186","volume":"17","author":[{"given":"Marco","family":"Gelpi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J.","family":"Hartling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per M.","family":"Ueland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Ullum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Tr\u00f8seid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6391-7455","authenticated-orcid":false,"given":"Susanne D.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,16]]},"reference":[{"key":"2456_CR1","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1056\/NEJMra1011874","volume":"364","author":"MSMMS Cohen","year":"2011","unstructured":"Cohen MSMMS, Shaw GGM, Mcmichael AJ, Haynes BF, et al. Acute HIV-1 Infection. N Engl J Med. 2011;364:1943\u201354. Available from: http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMra1011874","journal-title":"N Engl J Med"},{"key":"2456_CR2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/QAD.0000000000000520","volume":"29","author":"E Mutimura","year":"2015","unstructured":"Mutimura E, Addison D, Anastos K, Hoover D, Dusingize JC, Karenzie B, et al. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda. AIDS. 2015;29:67\u201376. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25396264","journal-title":"AIDS"},{"key":"2456_CR3","doi-asserted-by":"crossref","unstructured":"Ipp H, Zemlin AE, Erasmus RT, Glashoff RH, Ipp H, Zemlin AE, et al. Critical Reviews in Clinical Laboratory Sciences Role of inflammation in HIV-1 disease progression and prognosis. 2014;51(2):98\u2013111.","DOI":"10.3109\/10408363.2013.865702"},{"key":"2456_CR4","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/QAD.0000000000000243","volume":"28","author":"MT May","year":"2014","unstructured":"May MT, Gompels M, Delpech V, Porter K, Orkin C, Kegg S, et al. Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy. AIDS. 2014;28:1193\u2013202. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=4004637&tool=pmcentrez&rendertype=abstract","journal-title":"AIDS"},{"key":"2456_CR5","doi-asserted-by":"crossref","unstructured":"Opportunistic Infections Project Team of the Collaboration of, Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord. CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE. PLoS Med. 2012;9.","DOI":"10.1371\/journal.pmed.1001194"},{"key":"2456_CR6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/infdis\/jiu115","volume":"210","author":"H Byakwaga","year":"2014","unstructured":"Byakwaga H, Ii YB, Huang Y, Muzoora C, Kembabazi A, Weiser SD, et al. The Kynurenine Pathway of Tryptophan Mortality Among HIV-Infected Ugandans Initiating Antiretroviral Therapy. J Infect Dis. 2014;210:383\u201391.","journal-title":"J Infect Dis."},{"key":"2456_CR7","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1002\/prot.24653","volume":"82","author":"B Meng","year":"2014","unstructured":"Meng B, Wu D, Gu J, Ouyang S, Ding W, Liu Z-J. Structural and functional analyses of human tryptophan 2,3-dioxygenase. Proteins. 2014;82:3210\u20136. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25066423","journal-title":"Proteins"},{"key":"2456_CR8","doi-asserted-by":"crossref","first-page":"193ra91","DOI":"10.1126\/scitranslmed.3006438","volume":"5","author":"I Vujkovic-Cvijin","year":"2013","unstructured":"Vujkovic-Cvijin I, Dunham RM, Iwai S, Maher MC, Albright RG, Broadhurst MJ, et al. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med. 2013;5:193ra91. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23843452","journal-title":"Sci Transl Med"},{"key":"2456_CR9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/QAI.0000000000000758","volume":"70","author":"JC Gaardbo","year":"2015","unstructured":"Gaardbo JC, Tr\u00f8seid M, Stiksrud B, Midttun \u00d8, Ueland PM, Ullum H, et al. Increased Tryptophan Catabolism is Associated with Increased Frequency of CD161+Tc17\/MAIT Cells, and Lower CD4+ T cell Count in HIV-1 infected Patients on cART after Two Years of Follow-up. J. Acquir. Immune Defic Syndr. 2015;70:228\u201335. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26470032%5Cn , http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26181815","journal-title":"Immune Defic Syndr"},{"key":"2456_CR10","doi-asserted-by":"crossref","first-page":"391984","DOI":"10.1155\/2013\/391984","volume":"2013","author":"Y Murakami","year":"2013","unstructured":"Murakami Y, Hoshi M, Imamura Y, Arioka Y, Yamamoto Y, Saito K, et al. Mediat Inflamm. 2013;2013:391984. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23476103","journal-title":"Mediat Inflamm"},{"key":"2456_CR11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1440-1711.2003.t01-1-01177.x","volume":"81","author":"JR Moffett","year":"2003","unstructured":"Moffett JR, Namboodiri MA. Tryptophan and the immune response. Immunol Cell Biol. 2003;81:247\u201365. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12848846","journal-title":"Immunol Cell Biol"},{"key":"2456_CR12","doi-asserted-by":"crossref","first-page":"32ra36","DOI":"10.1126\/scitranslmed.3000632","volume":"2","author":"D Favre","year":"2010","unstructured":"Favre D, Mold J, Hunt PW, Kanwar B, Loke P, Barbour JD, et al. Tryptophan Catabolism by Indoleamine 2,3-Dioxygenase 1 Alters the Balance of TH 17 to Regulatory T Cells in HIV Disease. Sci Transl Med. 2010;2:32ra36.","journal-title":"Sci Transl Med"},{"key":"2456_CR13","doi-asserted-by":"crossref","unstructured":"Yamada A, Akimoto H, Kagawa S, Guillemin GJ, Takikawa O. Proinflammatory cytokine interferon-?? increases induction of indoleamine 2,3-dioxygenase in monocytic cells primed with amyloid\u00a0?? peptide 1-42: Implications for the pathogenesis of Alzheimer\u2019s disease. J Neurochem. 2009;110:791\u2013800.","DOI":"10.1111\/j.1471-4159.2009.06175.x"},{"key":"2456_CR14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.it.2012.10.001","volume":"34","author":"DH Munn","year":"2013","unstructured":"Munn DH, Mellor AL. Indoleamine 2,3 dioxygenase and metabolic control of immune responses. Trends Immunol. 2013;34:137\u201343. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3594632","journal-title":"Trends Immunol"},{"key":"2456_CR15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/infdis\/jiv037","volume":"212","author":"MA Jenabian","year":"2015","unstructured":"Jenabian MA, El-Far M, Vyboh K, Kema I, Costiniuk CT, Thomas R, et al. Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection. J Infect Dis. 2015;212:355\u201366. Available from: http:\/\/jid.oxfordjournals.org\/lookup\/doi\/10.1093\/infdis\/jiv037","journal-title":"J Infect Dis"},{"key":"2456_CR16","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/clinchem\/44.4.858","volume":"44","author":"M Huengsberg","year":"1998","unstructured":"Huengsberg M, Winer JB, Gompels M, Round R, Ross J, Shahmanesh M. Serum kynurenine-to-tryptophan ratio increases with progressive disease in HIV-infected patients. Clin Chem. 1998;44:858\u201362. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9554499","journal-title":"Clin Chem"},{"key":"2456_CR17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1006\/clim.2002.5231","volume":"104","author":"R Zangerle","year":"2002","unstructured":"Zangerle R, Widner B, Quirchmair G, Neurauter G, Sarcletti M, Fuchs D. Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection. Clin Immunol. 2002;104:242\u20137. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12217334","journal-title":"Clin Immunol"},{"key":"2456_CR18","first-page":"3","volume":"9","author":"J Chen","year":"2014","unstructured":"Chen J, Shao J, Cai R, Shen Y, Zhang R, Liu L, et al. Anti-retroviral therapy decreases but does not normalize indoleamine 2,3-dioxygenase activity in HIV-infected patients. PLoS One. 2014;9:3\u201310.","journal-title":"PLoS One"},{"key":"2456_CR19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/QAI.0000000000000294","volume":"67","author":"EE Page","year":"2014","unstructured":"Page EE, Greathead L, Metcalf R, Clark S-A, Hart M, Fuchs D, et al. Loss of Th22 cells is associated with increased immune activation and IDO-1 activity in HIV-1 infection. J Acquir Immune Defic Syndr. 2014;67:227\u201335. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25314246","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2456_CR20","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1089\/jir.1990.10.599","volume":"10","author":"D Fuchs","year":"1990","unstructured":"Fuchs D, Forsman A, Hagberg L, Larsson M, Norkrans G, Reibnegger G, et al. Immune activation and decreased tryptophan in patients with HIV-1 infection. J Interf Res. 1990;10:599\u2013603. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2128302","journal-title":"J Interf Res"},{"key":"2456_CR21","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12879-015-1087-5","volume":"15","author":"P Bipath","year":"2015","unstructured":"Bipath P, Levay PF, Viljoen M. The kynurenine pathway activities in a sub-Saharan HIV\/AIDS population. BMC Infect Dis. 2015;15:346. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26285873","journal-title":"BMC Infect Dis"},{"key":"2456_CR22","doi-asserted-by":"crossref","unstructured":"Serrano-villar S, Sainz T, Lee SA, Hunt PW, Sinclair E, Shacklett BL, et al. HIV-Infected Individuals with Low CD4 \/ CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8 + T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality. 2014;10.","DOI":"10.1371\/journal.ppat.1004078"},{"key":"2456_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/908314","volume":"2012","author":"M-A Jenabian","year":"2012","unstructured":"Jenabian M-A, Ancuta P, Gilmore N, Routy J-P. Regulatory T Cells in HIV Infection: Can Immunotherapy Regulate the Regulator? Clin Dev Immunol. 2012;2012:1\u201312. Available from: http:\/\/www.hindawi.com\/journals\/jir\/2012\/908314\/","journal-title":"Clin Dev Immunol"},{"key":"2456_CR24","doi-asserted-by":"crossref","unstructured":"Krebs SJ, Ananworanich J. Immune activation during acute HIV infection and the impact of early antiretroviral therapy. Curr Opin HIV AIDS. 2015;163\u201372. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26599167","DOI":"10.1097\/COH.0000000000000228"},{"key":"2456_CR25","doi-asserted-by":"crossref","unstructured":"Schuetz A, Deleage C, Sereti I, Rerknimitr R, Phanuphak N, Phuang-Ngern Y, et al. Initiation of ART during Early Acute HIV Infection Preserves Mucosal Th17 Function and Reverses HIV-Related Immune Activation. PLoS Pathog. 2014;10","DOI":"10.1371\/journal.ppat.1004543"},{"key":"2456_CR26","doi-asserted-by":"crossref","unstructured":"Hartling HJ, Jespersen S, Gaardbo JC, Sambleben C, Thorsteinsson K, Gerstoft J, et al. Reduced IL-7R T cell expression and increased plasma sCD127 in late presenting HIV-infected individuals. J. Acquir. Immune Defic. Syndr. 2016; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27509242","DOI":"10.1097\/QAI.0000000000001153"},{"key":"2456_CR27","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-3083.2012.02725.x","volume":"76","author":"HJ Hartling","year":"2012","unstructured":"Hartling HJ, Gaardbo JC, Ronit A, Knudsen LS, Ullum H, Vainer B, et al. CD4+ and CD8+ regulatory T cells (Tregs) are elevated and display an active phenotype in patients with chronic HCV mono-infection and HIV\/HCV co-infection. Scand J Immunol. 2012;76:294\u2013305. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22671952","journal-title":"Scand J Immunol"},{"key":"2456_CR28","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/rcm.4013","volume":"23","author":"\u00d8 Midttun","year":"2009","unstructured":"Midttun \u00d8, Hustad S, Ueland PM. Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography\/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2009;23:1371\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19337982","journal-title":"Rapid Commun Mass Spectrom"},{"key":"2456_CR29","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1186\/s12879-016-1930-3","volume":"16","author":"M Gelpi","year":"2016","unstructured":"Gelpi M, Hartling HJ, Thorsteinsson K, Gerstoft J, Ullum H, Nielsen SD. Immune recovery in acute and chronic HIV infection and the impact of thymic stromal lymphopoietin. BMC Infect Dis. 2016;16:591. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27769179","journal-title":"BMC Infect Dis"},{"key":"2456_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0078146","volume":"8","author":"MA Jenabian","year":"2013","unstructured":"Jenabian MA, Patel M, Kema I, Kanagaratham C, Radzioch D, Th\u00e9bault P, et al. Distinct Tryptophan Catabolism and Th17\/Treg Balance in HIV Progressors and Elite Controllers. PLoS One. 2013;8:1\u201313.","journal-title":"PLoS One"},{"key":"2456_CR31","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1182\/blood-2003-09-3333","volume":"104","author":"SG Deeks","year":"2008","unstructured":"Deeks SG, Kitchen CMR, Liu L, Guo H, Gascon R, Narv\u00e1ez AB, et al. Immune activation set point during early HIV infection predicts subsequent CD4 + T-cell changes independent of viral load Immune activation set point during early HIV infection predicts subsequent CD4 \u03e9 T-cell changes independent of viral load. Blood. 2008;104:942\u20137.","journal-title":"Blood."},{"key":"2456_CR32","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1086\/314660","volume":"179","author":"JV Giorgi","year":"1999","unstructured":"Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, Jacobson LP, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis. 1999;179:859\u201370. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10068581","journal-title":"J Infect Dis"},{"key":"2456_CR33","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/infdis\/jiu238","volume":"210","author":"PW Hunt","year":"2014","unstructured":"Hunt PW, Sinclair E, Rodriguez B, Shive C, Clagett B, Funderburg N, et al. Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. J Infect Dis. 2014;210:1228\u201338. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24755434","journal-title":"J Infect Dis"},{"key":"2456_CR34","doi-asserted-by":"crossref","first-page":"6663","DOI":"10.4049\/jimmunol.167.11.6663","volume":"167","author":"DC Douek","year":"2001","unstructured":"Douek DC, Betts MR, Hill BJ, Little SJ, Lempicki R, Metcalf JA, et al. Evidence for increased T cell turnover and decreased thymic output in HIV infection. J Immunol. 2001;167:6663\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11714838","journal-title":"J Immunol"},{"key":"2456_CR35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/mi.2012.7","volume":"5","author":"J Lajoie","year":"2012","unstructured":"Lajoie J, Juno J, Burgener A, Rahman S, Mogk K, Wachihi C, et al. A distinct cytokine and chemokine profile at the genital mucosa is associated with HIV-1 protection among HIV-exposed seronegative commercial sex workers. Mucosal Immunol. 2012;5:277\u201387. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22318497","journal-title":"Mucosal Immunol"},{"key":"2456_CR36","doi-asserted-by":"crossref","unstructured":"Erlandson KM, Ng D, Jacobson LP, Margolick JB, Dobs AS, Palella FJ, et al. Inflammation, Immune Activation, Immunosenescence, and Hormonal Biomarkers in the Frailty-Related Phenotype of Men with or at Risk for HIV. J Infect Dis. 2016. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27799351","DOI":"10.1093\/infdis\/jiw523"},{"key":"2456_CR37","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1128\/JVI.01844-08","volume":"83","author":"AR Stacey","year":"2009","unstructured":"Stacey AR, Norris PJ, Qin L, Haygreen EA, Taylor E, Heitman J, et al. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol. 2009;83:3719\u201333. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19176632","journal-title":"J Virol"},{"key":"2456_CR38","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/glia.22734","volume":"63","author":"M Ott","year":"2015","unstructured":"Ott M, Litzenburger UM, Rauschenbach KJ, Bunse L, Ochs K, Sahm F, et al. Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway. Glia. 2015;63:78\u201390. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25132599","journal-title":"Glia"},{"key":"2456_CR39","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1097\/00002030-199610000-00018","volume":"10","author":"S Zanussi","year":"1996","unstructured":"Zanussi S, D\u2019Andrea M, Simonelli C, Tirelli U, De Paoli P. Serum levels of RANTES and MIP-1 alpha in HIV-positive long-term survivors and progressor patients. AIDS. 1996;10:1431\u20132. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8902075","journal-title":"AIDS"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2456-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T21:41:15Z","timestamp":1602106875000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2456-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,16]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2456"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2456-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,16]]},"article-number":"349"}}